Elixinol Wellness (AU:EXL) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Elixinol Wellness Limited has announced a change in the interests of its director, David Fenlon, following a capital consolidation where every 8 securities were consolidated into 1. This move, approved in the recent Extraordinary General Meeting, has adjusted Fenlon’s holdings to 625,294 fully paid ordinary shares and various performance rights and options.
For further insights into AU:EXL stock, check out TipRanks’ Stock Analysis page.
